Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07195812Phase 4Not Yet Recruiting

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

Role: collaborator

NCT06925334Phase 4Enrolling By Invitation

A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

Role: collaborator

NCT05794152Not ApplicableRecruiting

Wenzhou Gestational Diabetes Cohort

Role: collaborator

NCT06329999Not ApplicableRecruiting

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

Role: collaborator

NCT04915001Completed

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

NCT03971201Phase 2Unknown

A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Role: collaborator

NCT02887963Completed

Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women

Role: collaborator

All 8 trials loaded